https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52483 Wed 28 Feb 2024 15:03:49 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38852 P =.001), whereas those treated with CRT were more likely to have internal HNL only (74% vs 25%, P =.001). Conclusions: Chronic HNL is highly prevalent following multimodal treatment, and differences in HNL presentations exist between treatment modalities.]]> Wed 16 Feb 2022 15:27:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42119 3 months post HNC treatment and experiencing some form of HNL, participated in individual, semi‐structured interviews. Transcribed interviews underwent thematic analysis using an inductive approach, with subsequent member checking. Most participants felt their HNL impacted their swallowing and some had impacts on speech; although the impact on voice was less clear. Four themes emerged, including three themes relating to HNL and its impact on swallowing and speech: “it feels tight;” “it changes throughout the day;” “it requires daily self‐monitoring and management;” and a fourth general theme “it affects me in other ways.” Participants perceived direct impacts from HNL to swallowing and speech. They often experienced daily symptom fluctuations that required additional strategies during times of increased difficulty. Findings highlight the need to improve patient education regarding the functional impacts of HNL and the importance of self‐management.]]> Fri 26 Aug 2022 10:32:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38251 P <.004 and P =.006, respectively), diet modification (P <.001 both), and poorer patient-reported outcomes (P =.037 and P =.014, respectively). Conclusion: Increased swallowing issues can be expected in patients presenting with more severe external HNL and/or internal HNL following HNC treatment.]]> Fri 16 Feb 2024 15:08:00 AEDT ]]>